Thank you for Subscribing to Life Science Review Weekly Brief
Through TruAge PACE, TruDiagnostic is pleased to be one of the first to offer robust, third-generation clocks to the general public at an accessible price.
FREMONT, CA: Using a test that requires only a few drops of blood and two to three weeks for lab processing, older adults can utilize it to monitor the effects of therapies and real-time changes to lifelong health risks. TruDiagnostic has unveiled the debut of TruAge PACE, a groundbreaking test that monitors short-term changes in the rate of biological aging.
Biologically, aging is the gradual loss of function of human cells over time. This process can be monitored by analyzing molecular markers known as methylation and using sophisticated algorithms to sort these marks and establish a person's 'biological age.' Nonetheless, this ability to monitor aging depends on the algorithms' efficacy. Until recently, most algorithms were trained on chronological age, so they were unresponsive to interventions influencing the biological aging process.
In research on aging, this algorithm has demonstrated that persons with accelerated aging rates (PACE value larger than 1.0) are at a greater risk of adverse health outcomes, such as an increased risk of chronic illness diagnosis and mortality. Additionally, faster-aging groups had a greater long-term risk of cardiovascular disorders, Alzheimer's disease, and other chronic conditions. Faster aging is also correlated with life quality indicators such as balance, muscle mass, intelligence and mental processing speed, and even facial aging.
PACE demonstrated high precision and the capacity to respond positively to therapies known to ameliorate aging phenotypes. With PACE, individuals can now detect rapid aging at a young age and avoid it with preventative treatments as young adults instead of attempting to reverse the cumulative effects of aging that have begun to manifest later in life.